FR2805266B1 - COMPOSITIONS FOR USE IN CONTROLLING PARKIN ACTIVITY - Google Patents

COMPOSITIONS FOR USE IN CONTROLLING PARKIN ACTIVITY

Info

Publication number
FR2805266B1
FR2805266B1 FR0001980A FR0001980A FR2805266B1 FR 2805266 B1 FR2805266 B1 FR 2805266B1 FR 0001980 A FR0001980 A FR 0001980A FR 0001980 A FR0001980 A FR 0001980A FR 2805266 B1 FR2805266 B1 FR 2805266B1
Authority
FR
France
Prior art keywords
compositions
controlling
parkin activity
parkin
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0001980A
Other languages
French (fr)
Other versions
FR2805266A1 (en
Inventor
Laurent Pradier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0001980A priority Critical patent/FR2805266B1/en
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to JP2001560240A priority patent/JP4861590B2/en
Priority to PCT/FR2001/000461 priority patent/WO2001060857A2/en
Priority to KR1020027010630A priority patent/KR100811926B1/en
Priority to CA2400256A priority patent/CA2400256C/en
Priority to EP01907820A priority patent/EP1259606B1/en
Priority to IL15121101A priority patent/IL151211A0/en
Priority to PT01907820T priority patent/PT1259606E/en
Priority to DE60141948T priority patent/DE60141948D1/en
Priority to NZ520802A priority patent/NZ520802A/en
Priority to MXPA02007869A priority patent/MXPA02007869A/en
Priority to AT01907820T priority patent/ATE466083T1/en
Priority to AU2001235696A priority patent/AU2001235696A1/en
Priority to ES01907820T priority patent/ES2345318T3/en
Priority to DK01907820.3T priority patent/DK1259606T3/en
Priority to BR0108376-7A priority patent/BR0108376A/en
Priority to US09/785,548 priority patent/US7132396B2/en
Publication of FR2805266A1 publication Critical patent/FR2805266A1/en
Priority to IL151211A priority patent/IL151211A/en
Priority to ZA200206550A priority patent/ZA200206550B/en
Priority to NO20023914A priority patent/NO20023914L/en
Publication of FR2805266B1 publication Critical patent/FR2805266B1/en
Application granted granted Critical
Priority to US11/390,195 priority patent/US8273548B2/en
Priority to IL193310A priority patent/IL193310A/en
Priority to CY20101100700T priority patent/CY1111004T1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR0001980A 2000-02-17 2000-02-17 COMPOSITIONS FOR USE IN CONTROLLING PARKIN ACTIVITY Expired - Fee Related FR2805266B1 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
FR0001980A FR2805266B1 (en) 2000-02-17 2000-02-17 COMPOSITIONS FOR USE IN CONTROLLING PARKIN ACTIVITY
MXPA02007869A MXPA02007869A (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity.
ES01907820T ES2345318T3 (en) 2000-02-17 2001-02-15 COMPOSITIONS USED TO REGULATE THE ACTIVITY OF THE PARK.
CA2400256A CA2400256C (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity
EP01907820A EP1259606B1 (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity
IL15121101A IL151211A0 (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity
PT01907820T PT1259606E (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity
DE60141948T DE60141948D1 (en) 2000-02-17 2001-02-15 COMPOSITIONS TO BE USED TO CONTROL PARKINACTIVITY
NZ520802A NZ520802A (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity
PCT/FR2001/000461 WO2001060857A2 (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity
AT01907820T ATE466083T1 (en) 2000-02-17 2001-02-15 COMPOSITIONS USEFUL FOR CONTROLLING PARKING ACTIVITY
AU2001235696A AU2001235696A1 (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity
JP2001560240A JP4861590B2 (en) 2000-02-17 2001-02-15 Composition useful for regulating parkin activity
KR1020027010630A KR100811926B1 (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity
BR0108376-7A BR0108376A (en) 2000-02-17 2001-02-15 Compound, polypeptide, nucleic acid, vector, recombinant defective virus, antibody or antibody fragment or derivative, pharmaceutical composition, processes for the selection or characterization of active molecules and for the production of a peptide compound, protein, cell, and mammal not human
DK01907820.3T DK1259606T3 (en) 2000-02-17 2001-02-15 Compositions suitable for regulating parkin activity
US09/785,548 US7132396B2 (en) 2000-02-17 2001-02-20 Compositions which can be used for regulating the activity of parkin
IL151211A IL151211A (en) 2000-02-17 2002-08-12 Polypeptide that interacts with parkin. pharmaceutical compositions comprising the same for treating neurodegenerative pathologies and method for producing said polypeptide
ZA200206550A ZA200206550B (en) 2000-02-17 2002-08-15 Compositions useful for regulating parkin gene activity.
NO20023914A NO20023914L (en) 2000-02-17 2002-08-16 Preparations for use in regulating the activity of the parking network
US11/390,195 US8273548B2 (en) 2000-02-17 2006-03-28 Nucleic acids encoding a human PAP1 polypeptide
IL193310A IL193310A (en) 2000-02-17 2008-08-07 Antibody directed against a polypeptide that interacts with parkin and pharmaceutical compositions comprising the same
CY20101100700T CY1111004T1 (en) 2000-02-17 2010-07-27 USEFUL COMPOSITIONS FOR REGULATING PARKIN GENE ACTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0001980A FR2805266B1 (en) 2000-02-17 2000-02-17 COMPOSITIONS FOR USE IN CONTROLLING PARKIN ACTIVITY

Publications (2)

Publication Number Publication Date
FR2805266A1 FR2805266A1 (en) 2001-08-24
FR2805266B1 true FR2805266B1 (en) 2004-12-03

Family

ID=8847103

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0001980A Expired - Fee Related FR2805266B1 (en) 2000-02-17 2000-02-17 COMPOSITIONS FOR USE IN CONTROLLING PARKIN ACTIVITY

Country Status (6)

Country Link
JP (1) JP4861590B2 (en)
DK (1) DK1259606T3 (en)
ES (1) ES2345318T3 (en)
FR (1) FR2805266B1 (en)
PT (1) PT1259606E (en)
ZA (1) ZA200206550B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116254286B (en) * 2022-12-23 2024-07-12 厦门大学 Cyanamide-induced saccharomyces cerevisiae engineering bacteria and construction method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004500813A (en) * 1999-12-21 2004-01-15 インサイト・ゲノミックス・インコーポレイテッド Vesicle transport protein

Also Published As

Publication number Publication date
JP4861590B2 (en) 2012-01-25
ZA200206550B (en) 2003-12-19
DK1259606T3 (en) 2010-08-23
PT1259606E (en) 2010-08-02
ES2345318T3 (en) 2010-09-21
FR2805266A1 (en) 2001-08-24
JP2003523193A (en) 2003-08-05

Similar Documents

Publication Publication Date Title
DE69912223D1 (en) Methyl methacrylate composition
FR12C0010I2 (en) HERBICIDE COMPOSITION
MA27126A1 (en) 3'PROMEDICAMENTS OF 2'-DESOXY- β-L-NUCLEOSIDES
DE60106275T8 (en) DERMATOLOGICAL COMPOSITION
ATE392898T1 (en) ANTIPHLOGISTIC AGENTS
ATE232364T1 (en) CASTING COMPOSITION
FR2770408B1 (en) HANDLE FOR CATHETER
DE60015536D1 (en) LIQUID HERBICIDE COMPOSITION
FR2785155B3 (en) DECORATIVE ELEMENT STRUCTURE FOR HAIR
DE60008839D1 (en) Perfume composition
ID30054A (en) HIGH-DENSITY DETERGENT COMPOSITION
AR025731A1 (en) "DITIEPINO [6,5-B] BENZO-FUSIONATED PYRIDINS AND RELATED COMPOSITIONS AND METHODS"
ITVE20010021U1 (en) "PERFECTED HYDRAULIC JACK"
FR2780886B1 (en) SELF-MOISTURIZING COMPOSITION FOR THE SKIN
FR2805266B1 (en) COMPOSITIONS FOR USE IN CONTROLLING PARKIN ACTIVITY
DE10080787D2 (en) Microbiocidal composition
DE19781549T1 (en) Disinfectant composition "Weltolen"
FR2810197B1 (en) LIVESTOCK MIXER-DISPENSER
ITMI20011833A0 (en) AGENTS THAT REGULATE VASCULAR PERMEABILITY
IT242807Y1 (en) HORSESHOE
TR200000347A3 (en) Microbial transformation of 2-methylquinocalin.
FR2814063B1 (en) COSMETIC COMPOSITION FOR LIPS CARE
FR2804976B1 (en) AMORTIZING SOIL FOR ACTIVITY AREA
FR2818131B1 (en) COSMETIC COMPOSITION COMPRISING HEPARANASE
FR2761059B1 (en) COMPOSITION FOR MATCH BUTTON

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 16

ST Notification of lapse

Effective date: 20161028